Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.055
+0.093 (9.63%)
At close: May 1, 2026, 4:00 PM EDT
1.070
+0.015 (1.42%)
After-hours: May 1, 2026, 7:49 PM EDT
Sunshine Biopharma Employees
Sunshine Biopharma had 50 employees as of December 31, 2025. The number of employees decreased by 2 or -3.85% compared to the previous year.
Employees
50
Change (1Y)
-2
Growth (1Y)
-3.85%
Revenue / Employee
$726,118
Profits / Employee
-$119,507
Market Cap
5.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 50 | -2 | -3.85% | 50 | 0 |
| Dec 31, 2024 | 52 | 8 | 18.18% | 52 | 0 |
| Dec 31, 2023 | 44 | -2 | -4.35% | 44 | 0 |
| Dec 31, 2022 | 46 | 43 | 1,433.33% | 46 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| IM Cannabis | 95 |
| Biofrontera | 94 |
| China SXT Pharmaceuticals | 75 |
| cbdMD | 42 |
| RedHill Biopharma | 35 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 8 |
SBFM News
- 27 days ago - Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - Accesswire
- 6 months ago - Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) - Accesswire
- 6 months ago - Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea - Accesswire
- 6 months ago - Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline - Accesswire
- 7 months ago - Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin - Accesswire
- 7 months ago - Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM) - Accesswire
- 7 months ago - Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) - Accesswire
- 7 months ago - Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience - Accesswire